P. Lange

发表

Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma.

R. Figlin, A. Belldegrun, P. Lange, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects.

E. Messing, P. Lange, V. Jordan, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostate specific antigen and local recurrence after radical prostatectomy.

P. Lange, L. Moore, L. Moore, 1990, The Journal of urology.

Significance of prostatic intraepithelial neoplasia on prostate needle biopsy.

P. Lange, M. Brawer, S. Bigler, 1991, Urology.

L. Schwartz, R. Figlin, S. Hancock, 2009, Cancer journal.

Radiation therapy as adjuvant treatment after radical prostatectomy.

P. Lange, E. Fraley, S. Levitt, 1988, NCI monographs : a publication of the National Cancer Institute.

Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment.

E. Messing, D. Lamm, P. Lange, 1996, The Journal of urology.

PROSTASCINT scan for staging prostate cancer.

P. Lange, P H Lange, P. Lange, 2001, Urology.

Future studies in localized prostate cancer. What should we think? What can we do?

P. Lange, P. Lange, 1994, The Journal of urology.

Words of wisdom: re: does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database.

P. Lange, 2013, European urology.

Is partial cystectomy the treatment of choice for mucinous adenocarcinoma of the urachus?

R. Santucci, L. True, P. Lange, 1997, Urology.

Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma.

P. Lange, J. Thompson, C. Collins, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IMPACT OF DELAY IN DIAGNOSIS ON CLINICAL STAGE OF TESTICULAR CANCER

P. Lange, G. Bosl, N. Vogelzang, 1981, The Lancet.

Use of CT to Reduce Understaging in Prostatic Cancer: Comparison With Conventional Staging Techniques

T. Emory, D. Reinke, D. E. Reinke, 1984 .